Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radioimmunoassay for serum thyroxine-binding globulin: results in normal subjects and in patients with hepatocellular carcinoma. [/sup 125/I]

Journal Article · · J. Clin. Endocrinol. Metab.; (United States)
Serum thyroxine-binding globulin (TBG) was measured by radioimmunoassay. The human TBG used in this study was purified by affinity, anion-exchange, and gel filtration chromatography. The serum TBG concentration in 98 euthyroid normals was 1.48 +- 0.46 mg/100 ml (mean +- SD), which is one-half that previously reported using a similar method. The level in females (1.66 +- 0.56) was significantly higher than that in males (1.37 +- 0.37). Comparison of the serum TBG level and the maximum binding capacity of serum TBG for thyroxine (T/sub 4/) yields a molar ratio of 1:1 for T/sub 4/ and TBG. The mean serum TBG in 19 patients with hepatocellular carcinoma was 2.10 +- 1.29 mg/100 ml; however, only two of these patients had serum TBG levels outside the normal range.
Research Organization:
National Inst. of Health, Bethesda, MD
OSTI ID:
7350735
Journal Information:
J. Clin. Endocrinol. Metab.; (United States), Journal Name: J. Clin. Endocrinol. Metab.; (United States) Vol. 42:5; ISSN JCEMA
Country of Publication:
United States
Language:
English